A detailed history of State Street Corp transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,471,215 shares of LXRX stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,471,215
Previous 2,313,477 6.82%
Holding current value
$2.05 Million
Previous $3.89 Million 0.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $238,184 - $376,993
157,738 Added 6.82%
2,471,215 $3.88 Million
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $501,989 - $743,204
325,967 Added 16.4%
2,313,477 $3.89 Million
Q1 2024

May 15, 2024

BUY
$1.3 - $3.58 $123,748 - $340,783
95,191 Added 5.03%
1,987,510 $4.77 Million
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.53 $16,180 - $24,755
16,180 Added 0.86%
1,892,319 $2.9 Million
Q3 2023

Nov 14, 2023

BUY
$1.06 - $2.33 $154,788 - $340,242
146,027 Added 8.44%
1,876,139 $2.04 Million
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.49 $356,930 - $579,388
166,014 Added 10.61%
1,730,112 $3.96 Million
Q1 2023

May 15, 2023

BUY
$1.99 - $2.68 $94,769 - $127,629
47,623 Added 3.14%
1,564,098 $3.8 Million
Q4 2022

Feb 14, 2023

BUY
$1.8 - $2.56 $95,230 - $135,439
52,906 Added 3.61%
1,516,475 $2.9 Million
Q3 2022

Nov 15, 2022

BUY
$1.94 - $3.43 $216,441 - $382,678
111,568 Added 8.25%
1,463,569 $3.51 Million
Q2 2022

Aug 15, 2022

BUY
$1.31 - $2.69 $36,176 - $74,287
27,616 Added 2.09%
1,352,001 $2.52 Million
Q1 2022

May 16, 2022

BUY
$1.95 - $3.89 $213,265 - $425,437
109,367 Added 9.0%
1,324,385 $2.77 Million
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $431,539 - $697,712
113,265 Added 10.28%
1,215,018 $4.79 Million
Q3 2021

Nov 15, 2021

BUY
$3.38 - $5.35 $216,678 - $342,967
64,106 Added 6.18%
1,101,753 $5.3 Million
Q2 2021

Aug 16, 2021

BUY
$4.12 - $5.87 $1.18 Million - $1.69 Million
287,262 Added 38.28%
1,037,647 $4.76 Million
Q1 2021

May 17, 2021

BUY
$3.45 - $9.09 $75,178 - $198,080
21,791 Added 2.99%
750,385 $4.41 Million
Q4 2020

Feb 16, 2021

SELL
$1.05 - $3.67 $22,329 - $78,046
-21,266 Reduced 2.84%
728,594 $2.49 Million
Q3 2020

Nov 10, 2020

BUY
$1.44 - $2.1 $5,647 - $8,236
3,922 Added 0.53%
749,860 $1.08 Million
Q2 2020

Aug 14, 2020

SELL
$1.75 - $2.3 $141,538 - $186,021
-80,879 Reduced 9.78%
745,938 $1.49 Million
Q1 2020

May 11, 2020

BUY
$1.8 - $4.28 $1.49 Million - $3.54 Million
826,817 New
826,817 $1.61 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.